Cargando…
Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936063/ https://www.ncbi.nlm.nih.gov/pubmed/35321430 http://dx.doi.org/10.3389/fonc.2022.872300 |
| _version_ | 1784672145140350976 |
|---|---|
| author | Ganjalikhani-Hakemi, Mazdak Xu, Ling Zamyatnin, Andrey A. Bazhin, Alexandr V. |
| author_facet | Ganjalikhani-Hakemi, Mazdak Xu, Ling Zamyatnin, Andrey A. Bazhin, Alexandr V. |
| author_sort | Ganjalikhani-Hakemi, Mazdak |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8936063 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89360632022-03-22 Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy Ganjalikhani-Hakemi, Mazdak Xu, Ling Zamyatnin, Andrey A. Bazhin, Alexandr V. Front Oncol Oncology Frontiers Media S.A. 2022-03-07 /pmc/articles/PMC8936063/ /pubmed/35321430 http://dx.doi.org/10.3389/fonc.2022.872300 Text en Copyright © 2022 Ganjalikhani-Hakemi, Xu, Zamyatnin and Bazhin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Ganjalikhani-Hakemi, Mazdak Xu, Ling Zamyatnin, Andrey A. Bazhin, Alexandr V. Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy |
| title | Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy |
| title_full | Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy |
| title_fullStr | Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy |
| title_full_unstemmed | Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy |
| title_short | Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy |
| title_sort | editorial: cellular and molecular mechanisms of immune checkpoint blockers in anti-leukemia/lymphoma immune therapy |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936063/ https://www.ncbi.nlm.nih.gov/pubmed/35321430 http://dx.doi.org/10.3389/fonc.2022.872300 |
| work_keys_str_mv | AT ganjalikhanihakemimazdak editorialcellularandmolecularmechanismsofimmunecheckpointblockersinantileukemialymphomaimmunetherapy AT xuling editorialcellularandmolecularmechanismsofimmunecheckpointblockersinantileukemialymphomaimmunetherapy AT zamyatninandreya editorialcellularandmolecularmechanismsofimmunecheckpointblockersinantileukemialymphomaimmunetherapy AT bazhinalexandrv editorialcellularandmolecularmechanismsofimmunecheckpointblockersinantileukemialymphomaimmunetherapy |